EUVIMEDEUVIMED entdecken
Fallbericht

Brief Report: Evaluation of Molecular Profiling Strategies for Neoadjuvant Osimertinib in Stage IIIA EGFR-Mutant NSCLC

Kevin Lu, Brian D Woodward, Joshua Boys, Mark Onaitis, Hatim Husain

Clinical Lung Cancer · 2024

DOI: 10.1016/j.cllc.2023.08.012 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Lung Cancer, 2024. Verfasst von Kevin Lu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California, San Diego, La Jolla, CA. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Acrylamides, Aniline Compounds. Die Arbeit nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoma, Non-Small-Cell LungAcrylamidesAniline CompoundsIndolesPyrimidinesHumansNeoadjuvant TherapyErbB ReceptorsMutationProtein Kinase Inhibitors

Stichwörter der Autor:innen

Circulating tumor DNAEGFR mutationNeoadjuvant therapyNon-small cell lung cancerOsimertinib

Substanzen

osimertinibErbB ReceptorsProtein Kinase InhibitorsEGFR protein, humanAcrylamidesAniline CompoundsIndolesPyrimidines

Autor:innen und Institutionen

  • Department of Medicine, University of California, San Diego, La Jolla, CA.
  • Department of Surgery, University of California, San Diego, La Jolla, CA.
  • Department of Medicine, University of California, San Diego, La Jolla, CA. Electronic address: hhusain@ucsd.edu.

Zitieren

APA

Lu, K., Woodward, B. D., Boys, J., Onaitis, M., & Husain, H. (2024). Brief Report: Evaluation of Molecular Profiling Strategies for Neoadjuvant Osimertinib in Stage IIIA EGFR-Mutant NSCLC. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2023.08.012

Vancouver

Lu K, Woodward BD, Boys J, Onaitis M, Husain H. Brief Report: Evaluation of Molecular Profiling Strategies for Neoadjuvant Osimertinib in Stage IIIA EGFR-Mutant NSCLC. Clinical Lung Cancer. 2024. doi:10.1016/j.cllc.2023.08.012

BibTeX
@article{Lu2024,
  author = {Lu, Kevin and Woodward, Brian D and Boys, Joshua and Onaitis, Mark and Husain, Hatim},
  title = {Brief Report: Evaluation of Molecular Profiling Strategies for Neoadjuvant Osimertinib in Stage IIIA EGFR-Mutant NSCLC},
  journal = {Clinical Lung Cancer},
  year = {2024},
  doi = {10.1016/j.cllc.2023.08.012}
}
Kostenlos starten →